Lilly Goes on $20B Buying Spree as It Seeks Next Act
✨ AI Summary
🔊 جاري الاستماع
Bloomberg's Michelle Davis joins Dani Burger on "Bloomberg Deals." Eli Lilly is on a record spending spree, announcing acquisitions worth more than $20 billion so far in 2026 as the drugmaker expands beyond its blockbuster obesity franchise. (Source: Bloomberg)
